Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
MetadataShow full item record
Tissue fibrosis is a core pathologic process that contributes to mortality in ~45% of the population and is likely to be influenced by the host genetic architecture. Here we demonstrate, using liver disease as a model, that a single-nucleotide polymorphism (rs12979860) in the intronic region of interferon-λ4 (IFNL4) is a strong predictor of fibrosis in an aetiology-independent manner. In a cohort of 4,172 patients, including 3,129 with chronic hepatitis C (CHC), 555 with chronic hepatitis B (CHB) and 488 with non-alcoholic fatty liver disease (NAFLD), those with rs12979860CC have greater hepatic inflammation and fibrosis. In CHC, those with rs12979860CC also have greater stage-constant and stage-specific fibrosis progression rates (P<0.0001 for all). The impact of rs12979860 genotypes on fibrosis is maximal in young females, especially those with HCV genotype 3. These findings establish rs12979860 genotype as a strong aetiology-independent predictor of tissue inflammation and fibrosis.
Place of Publication
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis Smart, NA; King, N; McFarlane, JR; Graham, PL; Dieberg, G (2016-06-17)
Histological study of liver, posterior intestine and white muscle of Oncorhynchus mykiss (Walbaum, 1792) and liver of Rachycentron canadum (Linnaeus, 1766) fed diets containing varying inclusions of polychaete worm meal Wareing, RossAmy (University of Plymouth, 2007)The unsustainability of fish meal and fish oil supplies for aquaculture feeds has encouraged the development of alternative protein sources. A relatively new alternative source of protein for fish meal is made from polychaete ...
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes Eslam, M; Mangia, A; Berg, T; Chan, HLY; Irving, WL; Dore, GJ; Abate, ML; Bugianesi, E; Adams, LA; Najim, MAM; Miele, L; Weltman, M; Mollison, L; Cheng, W; Riordan, S; Fischer, J; Romero-Gomez, M; Spengler, U; Nattermann, J; Rahme, A; Sheridan, D; Booth, DR; McLeod, D; Powell, E; Liddle, C; Douglas, MW; van der Poorten, D; George, J (2016-06-22)